Related Experiment Video
Updated: Mar 11, 2026

Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
Published on: June 30, 2016
Orn-mediated c-di-GMP regulates the CRISPR-Cas system to confer stress response in Mycobacterium tuberculosis
Wenjing Yu1,2, Lisha Yuan1, Wei Zhou1
1State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.
Abstract:
Mycobacterium tuberculosis (Mtb) possesses a type III-A CRISPR-Cas system and has anti-plasmid immune activity. However, whether this system exerts other additional functions remains to be characterized. Here, we investigated the in vivo roles of the Mtb CRISPR-Cas system. We show that this system is transcriptionally dependent and exhibits limited ability to counteract exogenous nucleic acids, primarily through the Csm6 protein rather than the Cas10 HD domain. We further demonstrate that this system plays a role in mitigating oxidative stress and antibiotic treatment, a function mainly mediated by the Cas10 HD domain. Importantly, through transposon library screening, we identified oligoribonuclease (Orn) as a regulatory protein of the Mtb CRISPR-Cas system. Deletion of the orn gene resulted in elevated c-di-GMP levels. A subsequent biotin-labeled c-di-GMP pull-down assay identified the transcriptional regulator Rv3058. Knockdown of rv3058 significantly increased cas6 promoter activity, and its transcriptional repressor function was directly modulated by c-di-GMP. This regulatory pathway enhances stress defense by activating multiple protective pathways, including DNA repair, cell envelope maintenance, and iron homeostasis regulation. Together, we conclude that the regulation of the CRISPR-Cas system by Orn-mediated c-di-GMP contributes to oxidative and antibiotic stress responses in Mtb.
Insights
The Mycobacterium tuberculosis CRISPR-Cas system helps bacteria survive oxidative and antibiotic stress. This defense is regulated by oligoribonuclease (Orn) and cyclic di-GMP (c-di-GMP), activating protective pathways.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Mycobacterium tuberculosis (Mtb) has a type III-A CRISPR-Cas system with known anti-plasmid activity.
- The full functional repertoire of the Mtb CRISPR-Cas system, particularly its role beyond plasmid defense, requires further investigation.
Purpose of the Study:
- To elucidate the in vivo functions of the Mtb CRISPR-Cas system.
- To identify regulatory mechanisms controlling the Mtb CRISPR-Cas system's activity.
Main Methods:
- Investigated CRISPR-Cas system activity in Mtb under various stress conditions.
- Utilized transposon sequencing (Tn-seq) to identify genetic regulators.
- Performed pull-down assays to identify protein interactions and characterized transcriptional regulation.
Main Results:
- The Mtb CRISPR-Cas system is transcriptionally regulated and primarily functions via Csm6 against exogenous nucleic acids.
- The Cas10 HD domain is crucial for mitigating oxidative and antibiotic stress.
- Oligoribonuclease (Orn) regulates the CRISPR-Cas system by modulating cyclic di-GMP (c-di-GMP) levels, which in turn affects the transcriptional repressor Rv3058.
- This pathway activates stress defense mechanisms including DNA repair and iron homeostasis.
Conclusions:
- The Mtb CRISPR-Cas system plays a significant role in stress adaptation beyond plasmid immunity.
- Orn-mediated c-di-GMP signaling is a key regulatory mechanism controlling the CRISPR-Cas system's contribution to Mtb's survival under stress.
Related Concept Videos
Other Stress Responses in Bacteria
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Stringent Response in E. coli
The Antiviral System of Bacteria and Archaea: CRISPR
Global Regulatory Systems
CRISPR/Cas9 Genome Editing

